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1. Introduction 
Radiological imaging plays a central role in the diagnosis, and treatment, of deep venous 
thrombosis (DVT) in the upper and lower limb. The intention of this chapter is not to 
distract the reader with a detailed account of the physics behind generating ultrasound (US), 
computed tomography (CT) and MR (magnetic resonance) vascular imaging. This would 
demand a chapter in its own right, and this information can be readily found in textbooks. 
Instead, emphasis will be placed on the clinical indications for requesting imaging in the 
diagnosis of DVT, as well as the potential limitations of these modalities. This will be 
supplemented with a review of current evidence and guidelines, and examples of the 
common image findings. The latest advances in venous MR imaging will be discussed, as 
will the role of interventional radiology in the treatment of DVT. Finally, considering that it 
is now universally accepted that DVT and pulmonary embolus (PE) are essentially 
manifestations of the same disease – namely, venous thromboembolism (Moser et al., 1994) 
– the imaging and radiological management of PE will also be addressed.  
2. Diagnostic imaging in venous thrombosis 
2.1 Historical venography 
Conventional venography (angiography) has traditionally been regarded as the “reference 
standard” for imaging the venous system (de Valois et al., 1990). This was performed by 
opacifying veins with iodinated contrast injected into the vessel via direct puncture, or 
targeted catheterisation usually from a punctured femoral vein at the groin (fig. 1). Venous 
imaging has always been challenging with angiography, in particular with the diagnosis of 
deep vein thrombosis (DVT). Completely occluded veins do not opacify and hence 
thrombosis has to be inferred rather than directly visualised. Unfortunately, this is 
compounded by the fact that even normal veins can be rendered invisible by virtue of the 
direction of venous flow towards the heart, which is counter to the diagnostic need. 
Contrast injection into an artery will reveal all the distal branches, but the same procedure in 
veins may not permit adequate visualisation of the tributaries. Furthermore, cannulation of 
peripheral veins can be hampered by the extent of limb swelling which accompanies DVT. 
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An additional problem is the small, but recognised, risk of actually causing thrombosis 
through the irritant effects of iodinated contrast medium on the vascular endothelium. 
Even allowing for these limitations, the continued use of conventional angiography is not 
sustainable in modern clinical practice considering it is a relatively time consuming and 
hence expensive procedure, and there is a growing demand on hospital Radiology 
departments to diagnose an increasingly prevalent disorder, affecting 200 per 100,000 of 
those aged 70- 79 years. The argument for providing a robust and efficient means of 
diagnosis is augmented by evidence that the initial clinical evaluation of DVT is often 
ineffective (Barnes et al., 1975; Haeger, 1969, as cited in Fraser & Anderson, 1999). Other 
conditions including lymphoedema, cellulitis, superficial phlebitis, muscle sprain and 
ruptured baker’s cyst can be indistinguishable from DVT. Indeed, seventy five percent of 
patients who present with signs and symptoms of DVT do not have the disease (Heijboer et 
al., 1993; Wells et al., 1995). 
 
Fig. 1. Lower limb venogram showing a normal superficial femoral vein. Note the normal 
valves (arrow). 
2.2 Ultrasound 
Ultrasound successfully addresses many of the above requirements, and has clearly become 
the first line imaging modality in suspected DVT (Cronan, 1993; Dorfman & Cronan, 1992). 
Unlike other modalities, it can also be a portable technique, allowing assessment of critically 
ill patients at the bedside. Cronan et al. gathered data from multiple studies to show a 
sensitivity of 95% and a specificity of 98% in detecting lower limb disease. The performance 
of venous ultrasound in the upper limb has been less studied, mainly because of the lower 
incidence of upper limb thrombus. However, the frequency of upper limb venous 
thrombosis is increasing considering that the two major risk factors are malignancy and 
central venous catheter placement (Allen et al., 2000; Baron et al., 1998). The performance of 
upper limb venous sonography should be high as ultrasound provides the highest spatial 
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resolution of any current imaging modality where veins are sonographically visible (Roditi 
& Fink, 2009). A relatively large study of upper limb venous sonography including over one 
hundred patients reported a sensitivity and specificity of 82% (Baarslag et al., 2002).  
The most accurate ultrasound tool for diagnosing DVT is compressibility of the vein in the 
transverse plane; a normally patent vein simply disappears when compressed by the 
ultrasound transducer (fig. 2). The maximum pressure required to obliterate a vein is much 
less than that required to deform the adjacent artery. Fortuitously, the entire deep venous 
system of the lower limb consists of arteries that parallel veins. Compression should not be 
performed in the longitudinal plane because the transducer may slide off the vessel with 
compression resulting in a false – positive finding. 
 
(a) (b) 
Fig. 2. (a) Transverse ultrasound of a normal left common femoral vein (V) and common 
femoral artery (A). (b) Transducer compression obliterates the vein, leaving the 
accompanying artery unaffected (A).  
Technique: In suspected lower limb DVT the veins are examined from the inguinal ligament 
(junction of the great saphenous vein of the superficial system with the common femoral 
vein of the deep system), to the popliteal vein within the popliteal fossa. There is varying 
opinion on the usefulness of assessing the distal calf veins, and they are not routinely 
scanned by the authors in whose institution’s protocol employs a repeat interval scan for 
those with high pre-test probability (see later). There is currently no consensus on what, if 
any, treatment is indicated in below knee thrombus (Righini, 2007; Schellong, 2007), and the 
reliability of compression US in excluding calf DVT has been questioned (Dauzat et al., 1997, 
as cited in Johnson et al., 2010; Kearon et al., 1998). A meta – analysis reported the sensitivity 
for detecting isolated calf DVT to be 73% (Kearon et al., 1998). Anticoagulation of calf DVT 
(that might spontaneously resolve) may unnecessarily place patients at increased risk of 
potential side effects of such medication, with an estimated 1.1% risk of major bleeding 
(Krakow & Ortel, 2005, as cited in Johnson et al., 2010). This particularly applies to frailer 
patients vulnerable to intra - cerebral haemorrhage from even innocuous trauma.  
Furthermore, the value of adding distal (calf) US to proximal US of the lower limbs for 
diagnosis of PE was investigated in a sub-analysis of a large, randomised trial. A total of 855 
patients with suspected PE underwent investigation by pre – test probability assessment, D-
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dimer testing, proximal US and computed tomography pulmonary angiography (CTPA). 
These patients also underwent distal US, although the findings of this investigation were not 
used in clinical diagnosis. A total of 59 patients had isolated distal DVT and, of these 59 
patients, 21 patients (36%) had no PE on CTPA. Of these 21 patients, 20 patients were not 
given anticoagulant therapy and had an uneventful follow-up. Thus, in patients with 
suspected PE, distal US has limited diagnostic value, and a high false positive rate, making 
it an investigation of limited value for diagnosis of PE (Righini et al., 2008). By contrast, 
because the vast majority of PEs arise from the pelvis or lower limb, and the treatment for 
proximal (above knee) DVT is identical to that for proven PE, a positive diagnosis of 
proximal DVT can eliminate the need to perform imaging of the pulmonary arteries. 
However, in clinical practice, many patients will have a CTPA, especially if they have 
respiratory symptoms. 
Venous compression technique is known as greyscale imaging. This can be augmented by 
performing colour Doppler - collectively known as duplex scanning. The Doppler effect is 
used to analyse blood flow by detecting the change in frequency of ultrasound waves that 
occurs when sound interacts with moving red blood cells. In the absence of DVT, variations 
in the Doppler waveform can be elicited by performing simple techniques. By squeezing the 
calf gently, known as augmentation, the Doppler flow within the venous system proximally 
increases as the muscle pump drives more blood towards the heart. This helps the operator 
to confidently exclude clot between the calf and the vein being visualised by the transducer. 
Another method is to ask the patient to take a deep breath. The increased intra – abdominal 
pressure during deep inspiration has a compressive effect upon the normal inferior vena 
cava and pelvic veins, causing a noticeable reduction in Doppler flow, thereby helping to 
excluded DVT within these proximal veins (fig. 3).  
 
Fig. 3. Duplex US. Normal phasic variation in Doppler waveform within the superficial 
femoral vein during deep respiration (arrow). 
Other indicators of thrombus include distension of the vein in acute thrombosis (typically 
long established clot does not expand the lumen), and visualising clot within the affected 
vein (fig. 4). Unfortunately, a significant number of acute clots are isoechoic i.e. of the same 
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ultrasound density to flowing blood, rendering them invisible to the naked eye unless 
colour mapping is used. Differentiating acute from chronic DVT is a challenge with all 
imaging modalities, not just ultrasound. The maturation of thrombus from anechoic i.e. less 
dense than blood, through to hyperechoic i.e. more dense is very variable, and exact age 
determination is not possible. Six months following a DVT, 50% of patients will have 
persisting abnormality on US (Dougherty RS & Brant WE, 2007), making the distinction 
between acute–on–chronic versus chronic changes very difficult. In addition to thrombus 
appearance, studies have assessed change in thrombus diameter (Kearon et al., 1998), 
change in thrombus length (Linkins et al., 2004), and Doppler analysis of flow (Prandoni et 
al., 2002) in an attempt to differentiate acute from chronic changes, but there remains no 
consensus on which ultrasound measurement can be relied upon to solve this potentially 
important dilemma. A sensible approach is to obtain a baseline scan at the time of 
discontinuing anticoagulation to allow for comparison in the event of the patient re–
presenting with recurring symptoms.  
 
(a) (b) 
Fig. 4. (a) Transverse image showing non – compressible DVT within the right common 
femoral vein on US. The lumen of the vein contains echogenic clot implying that it is 
relatively chronic (arrow). (b) Longitudinal Duplex image highlighting non – occlusive clot 
within the common femoral vein (arrow) with blood flowing around the thrombus. 
Venous Thrombi are dynamic structures, especially within the first 1 to 2 weeks after their 
onset (O’shaughnessy & Fitzgerald, 2000a, 2000b). Up to 25% of calf DVTs may propagate 
into the proximal veins (Johnson et al., 2010). Therefore, it is routine practice to repeat a 
negative scan after 5 to 7 days to assess for propagation into the proximal vasculature, 
particularly in patients with high pre–test probability scores. 
Importantly there are of course limitations to US. As discussed, the calf veins are not readily 
identified, especially in the swollen oedematous leg, often necessitating a repeat 
examination to exclude proximal clot propagation. In addition the iliac veins are not readily 
assessable, and the adductor canal (at the junction of the superficial femoral vein [SFV] and 
popliteal vein) is notoriously difficult to visualise even in thin patients. The saphenous vein 
or collaterals can be mistaken for the SFV. In addition, the SFV is duplicated in 
approximately 20% of patients, potentially leading to diagnostic error, particularly if one 
system is occluded and the other patent. Obesity and oedema can render examinations 
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inconclusive. Interestingly, studies have shown that whilst US is sensitive and specific for 
symptomatic lower limb DVT, it has rather poor sensitivity for asymptomatic DVT 
compared to conventional venography, with sensitivity between 29 and 38% (Davidson et 
al., 1992; Turkstra et al., 1997, as cited in Roditi & Fink, 2009). US has been investigated as a 
potential screening test in asymptomatic patients deemed to be at high risk of DVT 
following surgical procedures. However, the sensitivity and specificity appear to be reduced 
in this setting, a randomised – controlled trial discovering no added benefit of screening 
patients for DVT after lower limb arthroplasty surgery (Robinson et al., 1997, as cited in 
Fraser & Anderson, 1999). 
A final potential pit – fall is worth clarifying, especially for the referring clinician acting 
upon the radiological report. The superficial femoral vein is actually part of the deep venous 
system, and thrombus involving this vein could easily be interpreted as only a superficial 
phlebitis by the unaware clinician. The term should either be avoided, and replaced with the 
deep femoral vein (the practice of the authors), or the conclusion of the report should clearly 
indicate that there is DVT. 
2.3 Computed tomography and pulmonary embolus 
A study performed in 1994 showed that among patients with proximal DVT, approximately 
40% had an associated asymptomatic PE, supporting the belief that PE and DVT are 
essentially manifestations of the same disease, sharing similar risk factors (Moser et al., 
1994). Although PE can result from several embolic sources including air, fat, amniotic fluid 
and tumour, it has been estimated that PE originates from lower limb DVT in at least 90% of 
cases (Sevitt & Gallagher, 1961). Another common feature of these conditions is their rather 
non-specific presentation, with clinical signs often being of limited value in confirming a 
diagnosis (British Thoracic Society, 2003). Only a minority of patients presenting to the 
emergency department with classic pleuritic chest pain will have PE. Imaging again plays 
an essential role in diagnosis. 
Chest radiography will be the first radiological examination obtained in almost all patients 
presenting with PE, but a definitive diagnosis cannot be made on chest radiography alone. 
The majority of patients will have non-specific abnormalities such as airspace opacification, 
diaphragmatic elevation, linear atelectasis, and possibly cardiac silhouette changes. 
Conversely, a completely normal chest radiograph can be seen in up to 40%. The principal 
role of the plain chest radiograph is therefore to detect conditions that can mimic PE, such as 
pneumonia or pneumothorax. 
CTPA is now established as the first line investigation for the diagnosis of PE, surpassing 
ventilation/perfusion (V/Q) scans, most noticeably by reducing the number of 
indeterminate, non-diagnostic examinations (Johnson MS, 2002). In addition, CTPA has a 
superior inter – observer correlation (Blachere et al., 2000), with sensitivities of 94 – 96% and 
specificities of 94 – 100% being reported (Blachere et al., 2000; Remy-Jardin et al., 2000). 
Following targeted contrast opacification of the pulmonary arterial tree, multidetector CT 
allows evaluation of pulmonary vessels down to sixth order branches with the ability to 
reformat the original data in multiple planes to enhance the diagnostic accuracy (fig. 5). 
Emboli are recognised as intraluminal filling defects that partially or completely occlude the 
vessel. The most specific sign of acute PE is a filling defect that forms acute angles to the 
www.intechopen.com
 Radiological Imaging and Intervention in Venous Thrombosis 
 
85 
vessel wall. Clot forming an obtuse angle implies chronic thromboembolic disease, but this 
can also be seen in the acute setting. Secondary signs on CT reflect the non-specific 
abnormalities frequently seen on chest radiography. Pleural based wedge shaped 
consolidation indicates peripheral haemorrhage or infarction. Peripheral oligaemia (paucity 
of blood vessels distal to the occluded artery), pleural effusions and linear atelectasis (partial 
collapse) can also be observed.  
Detailed depiction of the lung parenchyma offers additional information not provided by V/Q 
scans (fig. 6b). In the context of a negative test for PE, an alternative explanation for the 
patient’s symptoms may be highlighted. A study found that as many as two – thirds of 
patients with an initial suspicion of PE received another diagnosis following CTPA (Hull et al., 
1994, as cited in Schoepf & Costello, 2004). In another study, CTPA identified pleural or 
parenchymal abnormalities that explained indeterminate defects on V/Q scans in 57% of 
patients (van Rossum et al., 1996, as cited in Kanne et al., 2004). Although a normal V/Q scan 
essentially excludes PE, a high probability scan has a sensitivity of 88%, compared to 94 – 96% 
for CTPA (Kanne et al., 2004). Patients with intermediate or indeterminate probability scans 
(because of background lung or pleural abnormalities) still have a 30 – 40% incidence of PE 
(Klein JS, 2007). V/Q scans, however, should always be considered in young patients with low 
pre-test probability and normal chest radiographs in view of its lower radiation dose.  
 
Fig. 5. CTPA in the axial (transverse) plane demonstrating bilateral filling defects within the 
contrast opacified pulmonary arteries diagnostic of PE (arrows). 
The main cause of death within the first 30 days after a PE is right ventricular failure 
(Schoepf et al., 2004). Right ventricular enlargement on CTPA has been shown to correlate 
with right ventricular dysfunction on echocardiography, and to predict early death from 
acute PE. In patients with confirmed PE, evidence of right heart strain / dysfunction should 
always be sought as this can influence patient management with regards reperfusion 
therapy. To accurately, and reproducibly, measure ventricular size the original CT data is 
manipulated to allow reformatting in the 4 chamber orientation. This is simply performed at 
the reporting workstation. The ventricle is measured at its maximum size at a level 1 cm 
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ahead of the corresponding atrioventricular valve. A right ventricle : left ventricle ratio of > 
0.9 is indicative of right ventricular enlargement (fig 6).  
CT venography (CTV) can be combined with CTPA to evaluate both PE and DVT in a single 
CT study (fig. 7). The lower limb veins are scanned at intervals 3 or 4 minutes following 
completion of the pulmonary angiogram. The sensitivity and specificity of CTV has been 
reported between 89 – 100% and 94 – 100% respectively (Begemann et al., 2003; Loud et al., 
2001, as sited in Kanne et al., 2004). The combined study also allows evaluation of the iliac 
system, not afforded by US. However, a major concern is the additional radiation exposure. 
A study found the addition of CTV to increase the gonadal dose by a factor of 500 in women 
and 2000 in men (the dose is higher in men since the testes are external to the body cavity). 
This translates to increased likelihood of birth defects and radiation – related death, albeit at 
a very low added risk (Rademaker et al., 2001). Combined CTV also requires substantial 
contrast medium dose for adequate venous opacification, significantly greater amounts than 
the relatively small quantities (50 - 75 ml) required for CTPA on modern multidetector 
scanners. The value of this combined study is therefore debatable, and CTV is not included 
in the CTPA protocol in most European institutions, including our own.  
 
(a) (b) 
Fig. 6. Coronal oblique reformatted CTPA at the level of the atrioventricular valves 
demonstrating right ventricular enlargement. (a) Maximum size of the left ventricle (line). 
LA = left atrium. (b) Maximum size of the right ventricle (line). RA = right atrium. The 
corresponding right ventricle : left ventricle ratio is > 0.9. Note the clot within the right 
pulmonary artery (arrowhead); and a lung tumour (arrow) which was not clinically suspected. 
The value of adding lower limb US in the evaluation of patients undergoing CTPA has been 
evaluated in a large, randomised trial of 1819 patients with clinically suspected PE. 
Following pre – test probability assessment, 909 patients were randomised to investigation 
by D-dimer measurement and CTPA, and 916 patients were randomised to D-dimer 
measurement, CTPA and venous US of the leg. The primary outcome was 3 month 
thromboembolic risk in patients who were left untreated on the basis of exclusion of PE by 
the investigation strategy. The prevalence of PE and the 3 month risk of thromboembolism 
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was the same in both investigation groups. Thus, venous US of the leg does not improve 
diagnosis of 3 month thromboembolic risk when added to investigation by D-dimer analysis 
and CTPA (Righini et al., 2008). Therefore, it can be argued that for patients who have 
undergone CTPA for the investigation of PE, US of the leg is a redundant investigation. 
The diagnostic power of current CT has provoked another interesting debate with the ability 
to potentially identify clot down to sixth order branches with multi – detector row scanners 
(MDCT). Older single detector row scanners (SDCT) have limited ability in detecting 
isolated subsegmental PE. Whilst the treatment of embolus detected within third and even 
fourth order subsegmental arteries is undisputed, the clinical relevance of detecting clot 
within smaller, more peripheral branches is questionable (Kanne et al., 2004), and could be 
unnecessarily subjecting patients to the side effects of anticoagulation. A review of 20 
prospective cohort studies and 2 randomised controlled trials was done to evaluate the 
importance of single and multiple detector row CTPA in the diagnosis of subsegmental PE. 
This meta-analysis showed that the diagnosis rate of sub-segmental PE was 4.7% with SDCT 
and 9.4% with MDCT. However, the 3 month risk of thromboembolic events in patients with 
suspected PE who were left untreated based upon a diagnostic algorithm that included a 
negative CTPA was 0.9% for SDCT and 1.1% for MDCT. Therefore, although MDCT 
increases the proportion of patients diagnosed with PE compared with SDCT, it does not 
substantially reduce the 3-month risk of thromboembolism. The authors suggest that 
isolated sub-segmental PE may not be clinically relevant (Carrier et al., 2006). Small 
peripheral emboli are believed to form even in healthy individuals (although this has never 
been substantiated); and it is a function of the lung to prevent these small clots from 
entering the arterial bed (Tetalman et al., 1973, as cited in Schoepf & Costello, 2004). 
 
Fig. 7. CTV (combined with CTPA) demonstrating clot within the left superficial femoral 
vein (arrow). 
2.4 Magnetic resonance imaging 
MRI has been perhaps underutilised in DVT because it is seen as relatively expensive, less 
accessible and more time consuming compared to other modalities. Furthermore, this 
probably also relates to the variability of venous enhancement encountered using the wide 
variety of imaging techniques available (Roditi & Fink, 2009). Despite this, MRI is 
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undergoing the greatest evolution in terms of venous imaging. Studies have already shown 
the sensitivity and specificity of MR venography (MRV) to be comparable to conventional 
venography in diagnosing femeropopliteal DVT (Cantwell et al., 2006; Fraser et al., 2002, as 
cited in Cantwell et al., 2006). Conventional venography is poor by comparison in 
opacifying the pelvic vessels (Cantwell et al., 2006; Spritzer, 2009). To reiterate, US also 
performs poorly in assessing the iliac vessels. Where MRV has perhaps until now performed 
less well than venography is in assessing the calf veins (Cantwell et al., 2006). With contrast 
enhanced MRV this was largely because of difficulties in predicting the arrival of contrast in 
the more distal veins to optimally time the acquisition of the images. This is confounded by 
the very short transit time of standard extracellular contrast agents within the vascular bed 
as they rapidly redistribute into the extracellular fluid space.  
Recent advancements in the physical properties of contrast agents have overcome the 
aforementioned difficulties in imaging the calf vessels. The “blood pool” contrast agent 
gadofosveset trisodium (Vasovist, Bayer Schering Pharma, Berlin, Germany) binds to 
plasma albumin extending the blood pool residence time. Not only does this eliminate time 
constraints in acquiring satisfactory images, but allows very high spatial resolution imaging 
of both the deep and superficial venous system (fig. 8). As previously mentioned, a potential 
pitfall of venography and US is the not uncommon occurrence of duplicated veins. A study 
investigating the effects of these anatomical variants in DVT suggested that DVT was twice 
as likely to be missed (Liu et al., 1986, as cited in Cantwell et al., 2006). Fig. 9 shows 
duplication of the SFV readily identified by high resolution MRI.  
 
(a) (b) 
Fig. 8. High resolution MRI using “blood pool” contrast allows excellent visualisation of both 
veins and their accompanying arteries. (a) Coronal plane. The normal anatomy of the calf 
arteries with their accompanying paired veins is clearly demonstrated with the anterior tibial 
artery and veins (arrowhead) and the peroneal artery and veins (straight arrow). The superficial 
(deep) femoral vein and artery are also shown (curved arrow). (b). Sagittal oblique view 
showing clot within the common femoral vein (arrow) and great saphenous vein (arrowhead). 
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The lack of radiation makes MRI a more attractive option than CT, particularly when there 
are concerns regarding pelvic DVT in younger patients as the reproductive organs are 
within the scanning field. For this reason, MRI should always be considered in excluding 
DVT in pregnancy. US is often equivocal especially in the latter stages due to technical 
difficulties. A further venous complication of pregnancy is ovarian vein thrombosis, or 
puerperal ovarian vein thrombophlebitis. Presentation is usually on the 2nd or 3rd day 
postpartum with lower abdominal pain and fever. The major complications are septicaemia 
and PE, which is reported to occur in up to 25%. MR is considered to be more sensitive than 
CT or US in making the diagnosis (Kubik-Huch RA et al., 1999, as cited in Spritzer, 2009). 
Several studies have evaluated the performance of pulmonary contrast enhanced MRA for the 
diagnosis of PE. One of the larger studies (Oudkerk et al., 2002, as cited in Roditi & Fink, 2009) 
assessed MRA in 141 patients with an abnormal perfusion lung scintigraphy and compared 
the findings with those of pulmonary DSA. Sensitivity was 77%, and the demonstration of 
emboli in two patients with a normal angiogram resulted in a specificity of 98%. The major 
advantage of MR is the lack of radiation exposure. A study has shown that the radiation from 
a single CTPA may cause an additional attributable lifetime risk of cancer of almost 1% in 
young women (Einstein et al., 2007, as cited in Roditi & Fink, 2009), mainly because breast 
tissue is relatively radiosensitive. With the introduction of “blood pool” contrast agents a 
comprehensive examination can be performed for PE and DVT using a single low dose 
contrast injection, without the associated radiation concerns that hamper CT.  
 
Fig. 9. High resolution MRI in the coronal plane showing duplication of the superficial 
femoral vein (arrow). Note that the superficial femoral artery is not visible because it was 
occluded at the groin. The patient had known claudication. 
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The limitations of MR are the relative expense limiting availability, and for some patients 
the claustrophobic environment preventing completion of the examination. At present, MRI 
should be considered when there is a strong clinical suspicion of pelvic DVT, and in young 
women requiring investigation for PE with abnormal chest X – ray precluding a V/Q scan.  
3. Role of interventional radiology in venous thrombosis 
3.1 Introduction 
Despite advances in diagnostic techniques and therapeutic approaches, DVT remains a 
potentially life threatening disorder. Anticoagulation, which is the current standard of 
treatment for patients with acutely diagnosed above knee DVT, involves treatment with low 
molecular weight heparin followed by a 6 month course of warfarin (Hyers et al., 1998). This 
treatment is designed to stop further progression and potential embolisation, but does not 
treat or remove the existing thrombus and may be insufficient in treatment of extensive ilio-
femoral thrombosis. A large clot burden in the proximal veins in the acute phase can lead to 
local complications including venous oedema, acute compartment syndrome, tissue necrosis 
and venous gangrene, and systemic complications such as PE. 
Over time normal fibrinolytic mechanisms will result in a variable degree of recanalisation 
of the thrombosed segment but this may not be sufficient for resolution of clinical 
symptoms. Chronic DVT and venous insufficiency has been shown to diminish a person`s 
quality of life and socioeconomic activity (Vedantham et al., 2004). 
There are a number of endovascular treatment options in DVT which aim to achieve 
thrombus removal, restoring patency and potentially limiting the acute complications 
associated with DVT. It is important to appreciate the limitations of these treatments and the 
relative lack of randomised controlled trials evaluating the efficacy of these interventions.  
3.2 Catheter directed thrombolysis treatment 
This technique involves infusion of a thrombolytic agent in and around the thrombus via an 
infusion catheter. This leads to high dose delivery of the thrombolytic agent locally, reducing 
the systemic complications, and has been shown to have almost double the venous patency 
rate at one year, compared to systemic thrombolysis (Comerota et al., 2007). This has been 
sanctioned by the American College of Chest Physicians (ACCP) as a first line treatment in 
“selected patients with extensive acute proximal DVT who have a low risk of bleeding” 
(Kearon et al., 2008). Further criteria include a young patient with a good functional status, life 
expectancy greater than one year and symptoms for ideally less than 14 days. 
Although the administration of the thrombolytic agent is local, the lytic agent can migrate 
systemically and can increase the risk for major bleeding complications requiring the patient 
to be monitored aggressively in a high dependency/intensive care setting. 
The route for catheter placement is usually decided depending on the thrombus location 
and burden. This may be placed via the jugular, contralateral femoral or ipsilateral popliteal 
vein, ideally using ultrasound guided access. Catheters with multiple side - holes and long 
infusion length can be used for drug delivery and although there is no single drug that has 
been approved for this use, streptokinase and more recently alteplase (rt-PA) have been 
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used for this purpose. Venography at the time of the procedure can help assess the clot 
burden, plan adjunctive treatments (venoplasty, pharmaco-mechanical disruption) and also 
help define a suitable end point.  
There is however a lack of prospective randomised data assessing the benefits of 
thrombolysis as compared to anticoagulant therapy (Pianta & Thomson, 2011). This, in 
combination with haemorrhagic complications and lack of awareness among physicians has 
limited acceptance of this procedure. 
3.3 Percutaneous mechanical thrombectomy and pharmacomechanical thrombolysis 
This involves use of a mechanical clot removal device such as a Trerotola (Arrow-
Trerotola™ PTD®, Arrow, Reading, PA) which is a rotational device or a hydrodynamic 
device such as Angiojet (AngioJet® Rheolytic Thrombectomy system: Medrad 
Intervention, Warrendale, PA) . Other devices such as Trellis (Cividien, Santa Clara, 
California) or the Clot Buster Amplatzer Thrombectomy Device (ATD, Minneapolis, MN) 
are also available.  
The aim is to achieve maceration/disruption of the clot, thus facilitating thrombus 
aspiration and removal. This is a much less invasive option than open surgical 
thrombectomy and other advantages include improved clot removal and more rapid 
restoration of flow. Intensive patient monitoring is also not necessary unlike catheter 
directed thrombolysis (fig. 10). 
 
(a) (b) 
Fig. 10. Catheter thrombectomy. (a) Catheter tip within the right main pulmonary artery, 
adjacent to embolus (arrow). (b) Post – treatment shows disruption of the clot. Note the 
striking difference in contrast opacification of the pulmonary arterial tree pre – and post – 
treatment. 
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Complications include vessel wall and valve injury and kidney failure due to haemolysis. 
Although patients can experience transient shortness of breath presumably due to 
pulmonary microemboli, experience gained from thrombectomy of clotted fistulas has 
shown that concomitant use of a plasminogen activator significantly reduced the risk of 
symptomatic pulmonary embolism from the procedure (O’Sullivan, 2010). 
Pharmacomechanical thrombolysis involves the combined use of a thrombectomy device 
in combination with catheter directed infusion of a thrombolytic agent. The advantages of 
this combination include better permeation of the thrombolytic agent and a smaller 
duration of treatment. Although some devices can lower the systemic dose of the drug, 
others do not do so. 
A retrospective study of 93 patients showed that pharmacomechanical thrombolysis was an 
effective treatment modality in patients with significant DVT and compared to catheter 
directed thrombolysis alone, it provided similar treatment success, reduced length of 
intensive care and hospital stay, and reduced hospital costs (Lin et al., 2006). However, 
another study has shown that that use of the Trerotola device alone constituted effective 
treatment of acute ilio-femoral DVT independent of adjunct pharmacological thrombolysis 
(Lee et al., 2006). 
There is, however, a relative lack of randomised data on the use of these devices and further 
randomised studies are necessary. 
3.4 Venoplasty and stenting 
Balloon venoplasty is usually performed in patients in combination with catheter directed 
thrombolysis or pharmacomechanical treatment to help macerate the existing clot or to 
dilate a venous stenosis which may have been a contributory factor in the development of 
the DVT. Venous stenosis can occur due a number of aetiologies. Benign causes include 
May-Thurner syndrome (Ferris et al., 1983), where long standing pulsatile compression of 
the left common iliac vein by the left common iliac artery leads to development of a venous 
web. Malignant compression or invasion can be another cause. Chronic deep vein 
thrombosis can lead to vessel wall fibrosis and development of stenosis.  
Unlike arteries, veins have a high elastic recoil and lower rates of flow which leads to less 
satisfactory results with long term stent patency, in the iliac veins, with a greater than 50% 
re-stenosis in up to 15% of patients (Hood & Alexander, 2004). These figures are much 
worse for patients who are hypercoagulable, have longer stent lengths and need infra-
inguinal stents.  
Stenting an underlying lesion has, however, shown to help prevent or prolong the interval 
to recurrence and can result in 50% increased patency rate than thrombolysis alone (Hood & 
Alexander, 2004) and lower recurrence rates of ilio-femoral DVT (up to 73% lower) in 
patients with May-Thurner syndrome (Oguzkurt et al., 2004). Most experience has been 
gained with Wallstents (Boston Scientific, Hemel Hempstead, Herts, UK) which are self 
expanding stents with a good radial strength. Studies have also shown the efficacy and 
durability of stents in the IVC (Ing et al., 2001; Razavi et al., 2000). 
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3.5 Inferior vena cava filters 
These percutaneously implantable devices are placed in the infra-renal inferior vena cava to 
reduce the risk of a significant pulmonary embolism (fig. 11). Specific indications include 
venous thromboembolism with a contraindication to oral anticoagulation or pulmonary 
embolism despite adequate anticoagulation (Kaufman et al., 2006). There are further uses 
including patients with DVT who have cancer or burns, and also in high risk trauma and 
surgical patients. Case selection is paramount and the risks of device implantation and 
removal must be carefully assessed. 
Device implantation is usually via the femoral or the internal jugular vein in a suitable 
infrarenal position. Cavograms are performed to delineate the renal veins, asses the extent 
of thrombus and exclude contraindications such as dilated IVC which may not be suitable 
for standard filter deployment. Suprarenal placement is undertaken if there is thrombus 
extension into or above the renal veins. 
 
Fig. 11. Temporary IVC filter (arrow). 
IVC filters are classified as temporary or permanent (Streiff, 2000) and there are various 
devices available that are approved for use. To cite a few examples, the Bird`s Nest Filter 
and the Trapease filter are permanent whereas the Gunther Tulip and the Cook Celect Filter 
are retrievable. Timely removal of retrievable filters is important to reduce the long term 
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risk of filter deployment. In terms of safety and efficacy, there is no significant difference 
between the two types of devices (Nazir et al., 2009). Complications associated with the 
device include those encountered at the time of insertion such as access site haematoma, 
pneumothorax, inadvertent arterial puncture and misplacement. Delayed complications 
include IVC thrombosis, occlusion, venous insufficiency and pulmonary embolism. 
4. Conclusion 
The incidence of deep venous thrombosis is increasing, not just in the lower limb but also 
within the deep veins of the upper limb, where malignancy and central venous catheter 
placement are the major precipitating factors. Ultrasound provides a rapid and readily 
available assessment, and can be portably used at the bedside in critically ill patients. There 
is however limitations to ultrasound, particularly the poor visualisation of below knee clot. 
In high risk patients, a short interval repeat scan is indicated to exclude the 25% of such clots 
which can propagate above the knee. 
The iliac veins within the pelvis are also inaccessible to ultrasound in almost every patient. 
If DVT is strongly suspected within the pelvis, MRI should be considered. This modality has 
seen the greatest advancements in recent times, with current protocols able to visualise the 
venous system in very high spatial resolution. CT angiography of the limbs, whilst sensitive 
and easily incorporated into routine CT pulmonary angiograph in suspected PE, should be 
avoided in view of the radiation burden. The major advantage of MRI is the lack of radiation 
exposure. MRI will almost certainly feature more commonly in DVT evaluation in the near 
future with new “blood pool” contrast agents allowing a comprehensive examination for PE 
and DVT in the same scan. One specific application is in relatively young patients with 
abnormal CXR precluding a V/Q scan. However, CT is currently the “gold standard” for 
diagnosing PE. 
There are a number of endovascular treatment options in DVT which aim to achieve 
thrombus removal, restoring patency and potentially limiting the acute complications 
associated with DVT. It is important to appreciate there are limitations to these 
treatments, with a relative lack of randomised controlled trials evaluating their true 
efficacy. They should however be given consideration in selected patients as outlined 
above. 
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